The Recall Desk
LowFDA (Devices)·Z-0539-2016·Announced 2015-12-30

Ameditech ProScreen Cup CLIA Drug Test Recall for Reduced Reactivity

Ameditech is recalling ProScreen Cup CLIA drug tests because they may show reduced reactivity for specific benzodiazepine compounds.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The agency classification is Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.

Plain-English summary

Ameditech Inc is recalling 743 kits of the ProScreen Cup CLIA with 6 Panel Drug, Item No. PSCup-6MB-W. The affected products were distributed nationwide.

The recall was initiated because the drugs of abuse tests have shown reduced reactivity for up to two of the nineteen benzodiazepine compounds listed in the product insert. The specific compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

The source text does not specify instructions for consumers or healthcare providers on how to handle the recalled units.

The recalled product

Product
ProScreen Cup CLIA with 6 Panel Drug, Item No. PSCup-6MB-W
Manufacturer
Ameditech Inc
Affected units
743

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • 142153 142594 143825 144227 152005 152972

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 59 products in this recall →